DSN
ABBV icon

D. Scott Neal’s AbbVie ABBV Stock Holding History

D. Scott Neal’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-80,056
Closed -$14.6M – 64
2024
Q1 		$14.6M Buy
80,056
+22,578
+39% +$3.89M 9.53% 2
2023
Q4 		$8.91M Sell
57,478
-1,095
-2% -$160K 7.94% 4
2023
Q3 		$8.73M Sell
58,573
-1,779
-3% -$261K 7.46% 5
2023
Q2 		$8.13M Buy
60,352
+2,747
+5% +$403K 6.11% 7
2023
Q1 		$9.18M Sell
57,605
-4,598
-7% -$703K 5.13% 3
2022
Q4 		$10.1M Sell
62,203
-779
-1% -$119K 4.88% 4
2022
Q3 		$8.45M Sell
62,982
-27,073
-30% -$3.88M 3.55% 6
2022
Q2 		$13.8M Buy
90,055
+86,219
+2,248% +$13.2M 5.74% 4
2022
Q1 		$622K Buy
3,836
+988
+35% +$144K 0.25% 34
2021
Q4 		$386K Buy
+2,848
New +$336K 0.15% 44
2018
Q3 		– Sell
-1,264
Closed -$117K – 35
2018
Q2 		$117K Sell
1,264
-889
-41% -$86.8K 0.07% 48
2018
Q1 		$204K Hold
2,153
– – 0.12% 36
2017
Q4 		$208K Hold
2,153
– – 0.12% 41
2017
Q3 		$191K Hold
2,153
– – 0.12% 39
2017
Q2 		$156K Sell
2,153
-700
-25% -$47.1K 0.11% 51
2017
Q1 		$186K Hold
2,853
– – 0.12% 44
2016
Q4 		$179K Hold
2,853
– – 0.13% 38
2016
Q3 		$180K Buy
2,853
+854
+43% +$55.3K 0.14% 32
2016
Q2 		$124K Buy
1,999
+1,035
+107% +$63.1K 0.11% 44
2016
Q1 		$55K Buy
964
+400
+71% +$22.3K 0.05% 58
2015
Q4 		$33K Buy
+564
New +$32.5K 0.03% 68

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

D. Scott Neal's ABBV Position: Q2 2024 in Review

D. Scott Neal sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 80,056 shares — an estimated $14.6M sold.

D. Scott Neal first reported a position in ABBV in Q4 2015 and held it in 21 quarters. The position peaked at $14.6M in Q1 2024. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • D. Scott Neal reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • D. Scott Neal sold 80,056 AbbVie shares in Q2 2024, an estimated $14.6M.
  • D. Scott Neal first reported a position in AbbVie in Q4 2015 and held it in 21 quarters.
  • D. Scott Neal's AbbVie position peaked at $14.6M in Q1 2024.
  • 3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on D. Scott Neal's 13F filing for Q2 2024, filed 15 Jul 2024.